RNA sequencing

#Cascade #Immune response #Nomic Bio #Parse Biosciences #Proteomics #QIAGEN #RNA sequencing #Single-cell RNA sequencing

Large-scale immune response dataset partnership

Proteomics company Nomic Bio and Parse Biosciences, a provider of single-cell sequencing and a QIAGEN company, have partnered to generate Cascade, a large-scale multimodal dataset designed to establish a foundational reference for healthy human immune response. Built using controlled perturbations across healthy donors, Cascade combines single-cell transcriptomic measurements with quantitative… Read More

#News

#Cancer Research Horizons #Genome sequencing #RNA sequencing #UK

Oesophageal cancer dataset made available for commercial use 

Cancer Research Horizons has made one the largest oesophageal cancer datasets available for commercial licensing.  Developed by a team led by Professor Rebecca Fitzgerald at the University of Cambridge, the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) dataset represents one of the world’s largest and most comprehensive collections… Read More

#Cancer Research #News

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

New DDW Highlights podcast: 22 April 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the… Read More

#News

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

This week in drug discovery (14-18 April) 

News round-up for 14-18 April by DDW Senior Digital Content Editor Diana Spencer. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. Read More

#News

RNA
#Collaboration #Inflammatory Bowel Disease #PacBio #RNA sequencing #Wellcome Sanger Institute

RNA mapping project focuses on inflammatory bowel disease

Scientists at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio) have launched a new initiative to map how gene activity shapes the immune system.  It is hoped that the project will identify new therapeutic targets for conditions such as inflammatory bowel disease (IBD). … Read More

#News

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

mRNA
#mRNA #Research and development #RNA sequencing #Takara Bio

New product could aid successful production of mRNA therapeutics

Takara Bio has launched PrimeCap T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development. PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA… Read More

#News

#Clinical Microbiomics #DNASense #Mergers and acquisitions #Microbiome #RNA sequencing

Clinical Microbiomics makes third acquisition in 18 months

Clinical Microbiomics has acquired DNASense, a Danish microbiome clinical research organisation (CRO) specialised in long-read DNA and RNA sequencing technologies and bioinformatics. The acquisition adds long-read DNA and RNA sequencing technologies to Clinical Microbiomics’ multi-omics technologies for the microbiome field. H Bjørn Nielsen, CSO… Read More

#Business & Investment #News

#3D chemistry #AI #Artificial intelligence (AI) #Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #Gene expression #Gene mutation #Interview #mRNA #Next generation sequencing #Oncology #PharmEnable #RNA sequencing #Single-cell RNA sequencing #Vaccines

Podcast: What trends will speed up the journey from clinic to bedside?

This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More

#News

RNA strand
#Covid-19 #RNA #RNA sequencing #Roundtable

Register now to join our roundtable on the delivery of RNA therapeutics

Hosted by DDW and sponsored by Azenta, ‘What are some of the biggest challenges related to the delivery of RNA therapeutics?’ will be free to attend on 27 September at 7am PST | 10am ET | 3PM BST | 4PM CET. Join this… Read More

Webinar date:
Sponsored by Azenta Life Sciences
#News

RNA
#Covid-19 #RNA #RNA sequencing #Roundtable

Roundtable: Panellists discuss the future RNA pipeline

Hosted by DDW and sponsored by Azenta, ‘What are some of the biggest challenges related to the delivery of RNA therapeutics?’ will be free to attend on 27 September at 7am PST | 10am ET | 3PM BST | 4PM CET. Join this… Read More

Webinar date:
Sponsored by Azenta Life Sciences
#News

microRNA
#Covid-19 #RNA #RNA sequencing #Roundtable

Roundtable: Discover how Covid-19 has influenced RNA research

Hosted by DDW and sponsored by Azenta, ‘What are some of the biggest challenges related to the delivery of RNA therapeutics?’ will be free to attend on 27 September at 7am PST | 10am ET | 3PM BST | 4PM CET. Join this… Read More

Webinar date:
Sponsored by Azenta Life Sciences
#News

RNA
#Covid-19 #RNA #RNA sequencing #Roundtable

What are the challenges in the delivery of RNA therapeutics?

Hosted by DDW and sponsored by Azenta, ‘What are some of the biggest challenges related to the delivery of RNA therapeutics?’ will be free to attend on 27 September at 7am PST | 10am ET | 3PM BST | 4PM CET. Join this… Read More

Webinar date:
Sponsored by Azenta Life Sciences
#News

RNA
#Covid-19 #RNA #RNA sequencing #Roundtable

Exclusive roundtable on the delivery of RNA therapeutics

Hosted by DDW and sponsored by Azenta, ‘What are some of the biggest challenges related to the delivery of RNA therapeutics?’ will be free to attend on 27 September at 7am PST | 10am ET | 3PM BST | 4PM CET. Join this… Read More

Webinar date:
Sponsored by Azenta Life Sciences
#News

RNA
#Covid-19 #RNA #RNA sequencing #Roundtable

What are some of the biggest challenges related to the development & delivery of RNA therapeutics?

In this roundtable, moderated by DDW and sponsored by Azenta Life Sciences, learn about the biggest challenges related to the delivery of RNA therapeutics. Roundtable panellists include Dr Philip Cruz, UK Medical Director, Moderna, Dr Neill Liptrott, Reader in Pharmacology and Immuno-compatability, University of Liverpool, and Reece Armstrong, Editor, DDW. Read More

Webinar date:
Sponsored by Azenta Life Sciences
#Webinars